Fujifilm Toyama Chemical Co. Ltd.
Division of Fujifilm Holdings Corp.
fftc.fujifilm.co.jp/en
Latest From Fujifilm Toyama Chemical Co. Ltd.
Coronavirus Update: Sinovac Gets $15m Towards CoronaVac Phase II, Remdesivir Early Access In UK
Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.
Strides Optimistic On COVID-19 Antivirals
Optimistic about the potential of repurposing its antivirals portfolio, Strides plans to soon begin bioequivalence studies for favipiravir, a molecule that has found favor as a COVID-19 therapy in a few countries. It also aims to introduce new products to fill the gap left by the withdrawal of ranitidine from the US market.
Strides Optimistic On Prospects Of Antiviral Portfolio For COVID-19
Optimistic about the potential of repurposing its antiviral portfolio, Strides plans to soon begin bioequivalence studies for favipiravir, a molecule that has found favor as a COVID-19 therapy in a few countries. It also aims to introduce new products to fill the gap left by the withdrawal of ranitidine from the US market.
Coronavirus Update: AstraZeneca To Develop Oxford’s Vaccine, Adaptive Trial Delivers Remdesivir's Good News
AstraZeneca is to develop and distribute Oxford's COVID-19 vaccine candidate in collaboration with Vaccitech. Its developers believe it could be available as early as September.
Company Information
- Industry
- In Vitro Diagnostics
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Cancer
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Toyama Chemical Co. Ltd.
- Fujifilm RI Pharma Co. Ltd.
- Ownership
- Private
- Headquarters
-
Worldwide
-
Asia
-
Pacific Rim
-
Japan
-
Japan
-
Pacific Rim
-
Asia
- Parent & Subsidiaries
- Fujifilm Holdings Corp.
- Senior Management
- Junji Okada, Pres.
- Contact Info
-
Fujifilm Toyama Chemical Co. Ltd.
Phone: (81) 3 5381 3889
14-1, Kyobashi 2-Chome
Chuo-ku
Tokyo ,
Japan